Legal Opinion
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
District Court, D. Delaware
Decided May 4, 2023No. 1:20-cv-01094Unknown
1Opinion
INTHEUNITEDSTATESDISTRICTCOURT FORTHEDISTRICTOFDELAWARE AZURITYPHARMACEUTICALS,INC., Plaintiff, CivilAction v. No. 20-cv-1094 ALKEMLABORATORIESLTD., Defendant. MEMORANDUMOPINION Goldberg,J.1 May4,2023 This lawsuit was brought under the Hatch Waxman Act for patent infringement pursuant to 35 U.S.C. § 271(e)(2)(a). Plaintiff Azurity Pharmaceuticals, Inc. (“Azurity”) claims that an Abbreviated New Drug Application (ANDA), submitted by Defendant Alkem Laboratories Ltd. (“Alkem”), infringes
U.S. Patent No. 10,959,948
(the ’948 patent), titled “Composition and…
2Cases cited19 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Vivid Technologies, Inc. v. American Science & Engineering, Inc.Court of Appeals for the Federal Circuit · 1999
- Multiform Desiccants, Inc., Plaintiff-Cross v. Medzam, Ltd.Court of Appeals for the Federal Circuit · 1998
- Summit 6, LLC v. Samsung Electronics Co., Ltd.Court of Appeals for the Federal Circuit · 2015
14 more not listed; retrieve them via the Exa API.